You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Seretide inhaler devices

 

Seretide contains two medicines, salmeterol xinafoate and fluticasone propionate. Seretide is for the treatment of asthma or COPD (Seretide Accuhaler 50/500mg dose only).

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

Seretide, Accuhaler and Evohaler are registered trademarks of the GlaxoSmithKline group of companies.